Randomized Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Booster (third Dose) of BNT162b2 COVID-19 Vaccine Coadministered with 20-Valent Pneumococcal Conjugate Vaccine in Adults ≥65 Years Old.
VACCINE（2023）
Key words
20-valent pneumococcal conjugate vaccine,Coadministration,COVID-19,SARS-CoV-2,Streptococcus pneumoniae
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined